In this task, you're given a paragraph and title from the research paper. Your task is to classify whether the given title is suitable or not for the research paper based on the given paragraph. Return "True" if title is proper according to paragraph else "False".

[Q]: Paragraph: To provide optimal cut-off values of anti-Middle East respiratory syndrome coronavirus (MERS-CoV) serologic tests, we evaluated performance of ELISA IgG, ELISA IgA, IFA IgM, and IFA IgG using 138 serum samples of 49 MERS-CoV-infected patients and 219 serum samples of 219 rRT-PCR-negative MERS-CoV-exposed healthcare personnel and patients. The performance analysis was conducted for two different purposes: (1) prediction of neutralization activity in MERS-CoV-infected patients, and (2) epidemiologic surveillance of MERS-CoV infections among MERS-CoV-exposed individuals. To evaluate performance according to serum collection time, we used 'days post onset of illness (dpoi)' and 'days post exposure (dpex)' assessing neutralization activity and infection diagnosis, respectively. Performance of serologic tests improved with delayed sampling time, being maximized after a seroconversion period. In predicting neutralization activity, ELISA IgG tests showed optimal performance using sera collected after 21 dpoi at cut-off values of OD ratio 0.4 (sensitivity 100% and specificity 100%), and ELISA IgA showed optimal performance using sera collected after 14 dpoi at cut-off value of OD ratio 0.2 (sensitivity 85.2% and specificity 100%). In diagnosis of MERS-CoV infection, ELISA IgG exhibited optimal performance using sera collected after 28 dpex, at a cut-off value of OD ratio 0.2 (sensitivity 97.3% and specificity 92.9%). These new breakpoints are markedly lower than previously suggested values (ELISA IgG OD ratio 1.1, sensitivity 34.8% and specificity 100% in the present data set), and the performance data help serologic tests to be practically used in the field of MERS management.
Title: Suggested new breakpoints of anti-MERS-CoV antibody ELISA titers: performance analysis of serologic tests
[A]: True

[Q]: Paragraph: The analysis of 26 longevity curves of different populations of inbred (Fischer 344) and outbred (Sprague-Dawley) rats highlighted a remarkable betweenpopulations variability in survival parameters. This variability is independent of the breeding characteristics of the strain. The two strains differed in the slope of the survival curves, with Fischer 344 rats showing a higher survival over the second year of life as well as a lower interindividual variability. A model-free approach based on principal component analysis allowed us to quantify these differences and to highlight some limitations of the classical Gompertzian approach.
Title: WITHIN-AND BETWEEN-STRAIN VARIABILITY IN LONGEVITY OF INBRED AND OUTBRED RATS UNDER THE SAME ENVIRONMENTAL CONDITIONS
[A]: False

[Q]: Paragraph: publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. Viral infections in solid transplant patients p M DHPG combinated with 5 U / d IFN (Y and 95 f 5% inhibition with 1 l . l p M DHPG in combination with 0.2 ng/d IFN y (n = 3). Conclusions: IFN (Y and IFN y decrease HCMV infection in monocytic-like cell line THP-1 and may lead to an improvement of the available chemotherapy against this important human pathogen. Combination of IFNs with DHPG after lnfection showed a synergistic effect. PCV has a well-documented inhibitory activity against herpes simplex virus and varicelia-zoster virus. By contrast, data on its activity against CMV are limited. We evaluated the in vim activity of PCV against 3 CMV WS (#1 and #2 from marmw transplant recipients, #3 from a neonate) and against CMV strain AD169, and compared the results with those obtained in parallel with acyclovir (ACV), ganciclovir (GCV), and foscarnet (FOS). A plaque reduction assay was used to determine the mhibitory drug concentration reducing plaque numbers by 50% (IC50). The drugs were tested in 6 human fibroblast cell lines. The results were as follows: Median ICsg of 13 p M (630) indxatmg a rerkunce to ganclclovlr.
Title: I P103q Activity of Penciclovir (PCV) in vitro against Cytomegalovirus (CMV) Wild Strains (WS) and against Strain AD169
[A]:
False